Paid Clinical Trials Everett
Discover 1,483 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Sponsor:
Allogene Therapeutics
Location:
Code:
NCT06500273
Conditions
Large B-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemacabtagene ansegedleucel
ALLO-647
Fludarabine
Cyclophosphamide
Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sponsor:
Sanofi
Location:
Code:
NCT06141473
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Frexalimab
Teriflunomide
Placebo infusion
Placebo tablet
MRI contrast-enhancing agents
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Sponsor:
Gilead Sciences
Location:
Code:
NCT03547973
Conditions
Metastatic Urothelial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Govitecan-hziy
Pembrolizumab
Cisplatin
Avelumab
Zimberelimab
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
Sponsor:
AbbVie
Location:
Code:
NCT05889182
Conditions
Hidradenitis Suppurativa
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Placebo
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Sponsor:
Seagen Inc.
Location:
Code:
NCT06003231
Conditions
Carcinoma, Squamous Cell of Head and Neck
Carcinoma, Non-Small-Cell Lung
Ovarian Neoplasms
Endometrial Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
disitamab vedotin
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Sponsor:
Stealth BioTherapeutics Inc.
Location:
Code:
NCT06373731
Conditions
Age Related Macular Degeneration (ARMD)
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Not accepted
Interventions
Elamipretide
Placebo
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Sponsor:
Seattle Institute for Biomedical and Clinical Research
Location:
Code:
NCT04049331
Conditions
Hypogonadism, Male
Fatigue Syndrome, Chronic
Eligibility Criteria
Sex: Male
Age: 18 - 54
Healthy Volunteers: Not accepted
Interventions
Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
placebo
Desara ® One Single Incision Sling 522 Study
Sponsor:
Caldera Medical, Inc.
Location:
Code:
NCT04772131
Conditions
Stress Urinary Incontinence
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Desara® One Single Incision Sling
Desara® Blue Transobturator Sling
Evaluating Treatments for Suicidal Veterans With PTSD
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT05974631
Conditions
Self-directed Violence
Post-traumatic Stress Disorder (PTSD)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dialectical Behavior Therapy
Dialectical Behavior Therapy Prolonged Exposure protocol
Prolonged Exposure therapy
Suicide risk management
A Phase 2 Study of Firi-cel in Patients with Relapsed/refractory Large B-cell Lymphoma
Sponsor:
CARGO Therapeutics
Location:
Code:
NCT05972720
Conditions
Cancer
Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fludarabine (Conditional therapy)
Cyclophosphamide Monohydrate (Conditional therapy)
firi-cel (Experimental drug)